Every transition, from preclinical to clinical to commercial, raises the compliance bar. Most teams meet it by rebuilding processes or calling in consultants. Qualio flips that order: build toward the frameworks that matter from the beginning.
Quality & Compliance for Biopharma
Preclinical rigor. Commercial-grade compliance. Same system throughout.
Qualio codifies clause-level GxP requirements into your quality system from day one, so when manufacturing comes in-house or investor and audit scrutiny intensify, the granular compliance record is already there.
Trusted by 400+ biopharma leaders
The Solution
Regulatory readiness, built-in from the start
Compliant from day 1
Build your quality and compliance system to align with clause-level ICH, FDA, and GxP requirements.
Stay ahead of regulatory change
Stay up-to-date with the latest guidelines, monitor for relevant updates and risks, and make changes before they become audit findings.
Reach regulatory milestones without the scramble
Qualio continuously maps your quality records against your active frameworks, so your evidence is always current and your team is always prepared.
The Results
80%
faster audit-readiness
60%
lower consultant spend
5x
ROI
Hard-wire GCP & GMP Compliance
- Built-in compliance with ICH, FDA, ISO and GxP requirements
- Ramp up for clinical trials without rebuilding
- Scale into GMP compliance smoothly: ICH Q7, Q8, Q9, Q10, and Q11, Eudralex, and more in one system
Scale faster with the same team
- Run GxP-compliant document control, change control, training, CAPA, and audit management in one validated system
- Compliance risk analysis refreshes as you evolve your QMS
- Scale across sites, programs, and departments without proportional compliance overhead
Don't just take our word for it!
Hear from our innovative customers
“Qualio simplified things immensely.”
Andrew Breite
Director of Quality Assurance, VitaCyte
“We needed something that was user-friendly, easy to onboard new team members, and easy to get up and running. Qualio has surpassed our expectations on those metrics.”
Stephana P.
VP of Quality, Alphazyme
“Using Qualio allowed management to review work in real time, mentor our team and build towards 'design-lock-ready' processes far more quickly than with a paper-based experimental tracking system.”
Christopher B.
CEO, Alphazyme
“With other vendors, we felt like just a number. But this is like a true partnership. Qualio has definitely changed our world.”
Eric D.
Director of Quality Assurance, Expression Therapeutics
“My favourite thing is how Qualio keeps us in a constant state of audit readiness.”
Deb G.
Director of Quality, Dimension Therapeutics
Related resources
More content for Biopharma professionals
See Qualio in Action